ImageCare Radiology is a premier provider of radioembolization, offering this advanced treatment to patients seeking innovative care. Our specialized team is committed to utilizing this targeted therapy to improve outcomes for individuals battling specific types of cancer.
Radioembolization, also known as Y-90 treatment, is a minimally invasive procedure that combines embolization and radiation therapy to treat liver tumors. It involves the delivery of tiny, radioactive beads (Yttrium-90) directly into the blood vessels that feed a liver tumor. Y-90 treatment is a form of brachytherapy, which means it delivers a high dose of radiation to the tumor while sparing the surrounding healthy tissue.
This sophisticated therapy works by blocking the tumor’s blood supply with the microspheres, which also emit radiation that helps to kill the cancer cells. The dual action of the Y-90 treatment not only deprives the tumor of the nutrients it needs to grow but also delivers potent radiation directly to the cancer site, making it an effective weapon in the fight against liver cancer. The procedure can lead to size reduction of tumors, a reduction in markers of tumor activity and an increase in overall survival time.
The radioembolization procedure involves the insertion of a small tube into an artery in the leg. This tube is then guided to the artery that supplies blood to the liver. An X-ray is taken to study the liver arteries, and any routes that travel outside of the liver are blocked to ensure that none of the powerful radiation damages other organs. The radiation treatment is completed in one or two sessions, depending on the blood supply to the liver. Many patients require two treatments because two separate arteries supply the liver. If this is the case, the treatments are separated by 30 days. During the procedure, the patient is given medication to relax and a local anesthetic to numb the area where the catheter is inserted. Most patients can go home on the same day as the radioembolization procedure.
Radioembolization is primarily used to treat cancers and tumors within the liver. This includes primary liver cancer, known as hepatocellular carcinoma, and metastatic liver tumors, which are cancers that have spread to the liver from other parts of the body. The therapy is especially beneficial for patients who may not be candidates for traditional surgery due to the location of the tumor or other health considerations.
It’s also an option for those whose tumors have not responded to chemotherapy or for individuals looking to reduce tumor size to become eligible for surgery. Y-90 treatment can be used as a standalone therapy or in conjunction with other treatments as part of a comprehensive cancer care plan.
While radioembolization side effects are generally fewer and less severe than those associated with systemic treatments like chemotherapy, patients may still experience some post-procedure effects. Common radioembolization side effects can include fatigue, mild abdominal pain, nausea, and fever. These symptoms typically subside within a week after treatment.
It is important to discuss all potential side effects with your doctor before undergoing radioembolization. The ImageCare Radiology team prioritizes patient education, ensuring individuals are well-informed about the benefits and risks associated with Y-90 treatment.
ImageCare Radiology is here to provide advanced radioembolization treatments across many convenient locations. Our state-of-the-art facilities are equipped with the latest in medical imaging technology, ensuring patients receive the highest quality care available.
If you or a loved one are considering radioembolization as a treatment option, we invite you to reach out to us. Our compassionate and knowledgeable radiology providers will guide you through the consultation process, answer your questions, and help you schedule a treatment. Contact ImageCare Radiology to explore how Y-90 treatment can be an integral part of your cancer care regimen. Let us support you on your journey to recovery and improved health.